real-time news and commentary for investors
Thursday, Nov 15
2012, 5:56 PM
Johnson & Johnson (JNJ), Merck (MRK) and Eli Lilly (LLY) are collaborating in a global...
Johnson & Johnson (JNJ), Merck (MRK) and Eli Lilly (LLY) are collaborating in a global project to create a database aimed at getting patient tests of experimental drugs up and running more quickly and efficiently, which would eventually mean new medicines will get approved and reach patients sooner. The database will give drug companies working on experimental drugs a one-time approval process and drug makers a big pool of ready, qualified scientists with known expertise.